celiac disease Gut Microbiome Study in Infants Identifies Alterations That May Contribute to Celiac Disease The researchers said their approach could be used to predict disease onset and, ultimately, to identify early preventive interventions. Adaptive Biotechnologies ImmunoSeq Dx Development Jolts Forward With Lyme Disease in Crosshairs Premium The immune sequencing firm has engaged the FDA in discussions over how to get regulatory approval for one test for several seemingly different diseases. Beyond Celiac Grants $160K for Transcriptomics Pilot Study The award will go to Jocelyn Silvester of Children's Hospital Boston, to fund transcriptomics research on intestinal inflammation caused by gluten. Adaptive Biotechnologies Plans New Product Launches, Expanded FDA Label for ClonoSeq Premium The immune sequencing firm is working on kit-ifying its two existing tests, as well as developing a second clinical test and expanding the label for clonoSeq. GeneATLAS Database Documents Diverse Trait Associations Detected With UK Biobank Data Researchers documented genetic associations, trait heritability, and more with data from GWAS on 778 binary or non-binary traits in UK Biobank participants. Mar 31, 2016 Celiac Disease Linked to Common Variant in Long Non-Coding RNA Oct 9, 2015 Researchers Estimate Heritability of Childhood Autoimmune Diseases Aug 24, 2015 Many Pediatric Autoimmune Disorders Share Altered Genetic Loci, Study Finds Jan 7, 2015 Oslo Team Uses Mass Spec to Characterize Gluten Peptide Binding in HLAs Linked to Celiac Disease Premium Dec 22, 2014 ImmusanT Nabs $12M Investment to Support Celiac Disease CDx and Immunotherapy Jul 3, 2014 Genomics in the Journals Jul 3, 2014 Feb 24, 2014 Canada Clears SQI Test for Celiac Disease Dec 13, 2011 ImmusanT Raises $20M to Support Celiac Disease CDx, Therapy Dec 6, 2011 In Realignment, SQI to Streamline IVD Pipeline, Build Revenue from New CustomPlex Offering Premium Jun 7, 2011 FDA Clears SQI Diagnostics' Platform, Test for Celiac Disease May 20, 2011 Thermo Fisher Adds to Specialty-Dx Business with $3.5B Phadia Buy Premium Apr 29, 2011 SQI's Second-generation Celiac Panel Gets Canadian Clearance Oct 28, 2010 Univ. of Maryland Gets $45M Gift to Support Autoimmune, Inflammatory Disease Research Nov 17, 2009 Biofortuna to Provide HLA Kits for Lab901's PCR-Based Diagnostic Platform Premium Feb 4, 2009 Navigenics Launches Cheaper Annual Genomic Service; Will Doctors Bite? Premium Breaking News FDA Revises SARS-CoV-2 Test Emergency Use Authorization Requirements to Account for Variants Geisinger Wins $5M NIH Grant to Develop Point-of-Care Genetic Diagnostic Tool Second Genome, Virginia Commonwealth University Partner on NASH Biomarker Discovery LGC Receives CE Mark for AccuPlex SARS-CoV-2, Flu A/B, RSV Reference Material Kit Esophageal Cancer Testing Firm Lucid Diagnostics Files For IPO Twist Bioscience, DeepCDR Collaborate on Antibody Library Design The Scan Booster for At-Risk The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people over 65 or at increased risk. Preprints OK to Mention Again Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications. Hundreds of Millions More to Share The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post. Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.